The Man Beat Cancer Years Ago. Why Was There a Mass in His Lung?
Could the disease be back? (Source: NYT Health)
Source: NYT Health - November 2, 2022 Category: Consumer Health News Authors: Lisa Sanders, M.D. Tags: Coccidioidomycosis (Valley Fever) Lungs Pneumonia Infections Coughs Arizona Source Type: news

Results of Novel Clinical Study of Guselkumab and Golimumab Combination Therapy Show Adults with Moderately to Severely Active Ulcerative Colitis Maintained Higher Rates of Clinical, Histologic, and Endoscopic Remission at Week 38
SPRING HOUSE, PENNSYLVANIA, October 10, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from an ongoing analysis of a Phase 2a clinical trial showing adults with moderately to severely active ulcerative colitis (UC) who received 12 weeks of combination induction therapy with guselkumab and golimumab, followed by a transition to guselkumab alone for maintenance, achieved a clinical remission ratea (based on the modified Mayo score [mMayo])b at week 38 of 47.9 percent, a higher rate than induction and maintenance treatment with either guselkumab alone (31.0 percent) or golimumab al...
Source: Johnson and Johnson - October 10, 2022 Category: Pharmaceuticals Source Type: news

Travel manager, 33, suffering back pain and weight loss diagnosed with valley fever
Desiree Chan's condition left doctors stumped after tests for pneumonia, tuberculosis and even HIV all came back negative. Valley fever is advancing in America, with cases doubling in five years. (Source: the Mail online | Health)
Source: the Mail online | Health - September 14, 2022 Category: Consumer Health News Source Type: news

It took everything ’: the disease that can be contracted by breathing California’s air
Valley fever, derived from a fungus that lives in the US south-west’s soil, is on the rise as climate crisis dries out the landscape #climatecrisis (Source: Reuters: Health)
Source: Reuters: Health - August 29, 2022 Category: Consumer Health News Source Type: news

Notes From the Field: Coccidioidomycosis Outbreak Among Wildland Firefighters - California, 2021
This report describes a coccidioidomycosis (Valley Fever) outbreak among wildland firefighters in California during 2021. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - August 25, 2022 Category: American Health Tags: Fire Fighters MMWR Morbidity & Mortality Weekly Report Outbreaks Public Health Valley Fever (Coccidioidomycosis) Source Type: news

CDC Characterizes National Incidence of Fungal Infections
THURSDAY, Aug. 18, 2022 -- Coccidioidomycosis, histoplasmosis, and blastomycosis cause substantial illness, with about 20,000 cases of coccidioidomycosis reported in 2019, according to research published in the Aug. 19 issue of the U.S. Centers for... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 18, 2022 Category: Pharmaceuticals Source Type: news

SURVEILLANCE SUMMARIES: Surveillance for Coccidioidomycosis, Histoplasmosis, and Blastomycosis - United States, 2019
This report describes U.S. coccidioidomycosis, histoplasmosis, and blastomycosis cases in 2019 (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - August 18, 2022 Category: American Health Tags: Blastomycosis Histoplasmosis (Histoplasma capsulatum Disease) MMWR MMWR Summaries Morbidity & Mortality Weekly Report National Notifiable Diseases Public Health Valley Fever (Coccidioidomycosis) Source Type: news

Surveillance for Coccidioidomycosis, Histoplasmosis, and Blastomycosis - United States, 2019
This report describes U.S. coccidioidomycosis, histoplasmosis, and blastomycosis cases in 2019 (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - August 18, 2022 Category: American Health Tags: Blastomycosis Histoplasmosis (Histoplasma capsulatum Disease) MMWR MMWR Summaries Morbidity & Mortality Weekly Report National Notifiable Diseases Public Health Valley Fever (Coccidioidomycosis) Source Type: news

Potentially Deadly Bacteria Detected in U.S. Soil for First Time
The bacteria, Burkholderia pseudomallei, was found along the Gulf Coast region of Southern Mississippi. Previously, it had been detected in parts of Asia and Australia. (Source: NYT Health)
Source: NYT Health - July 28, 2022 Category: Consumer Health News Authors: McKenna Oxenden Tags: Bacteria Coccidioidomycosis (Valley Fever) Centers for Disease Control and Prevention Far East, South and Southeast Asia and Pacific Areas Gulf Coast (US) Mississippi United States Source Type: news

Warning: Climate Crisis Is Now the Single Biggest Health Threat Facing Humanity
This year’s World Health Day launched a new warning: more than 13 million deaths around the world each year are due to “avoidable environmental causes”. Credit: BigstockBy Baher KamalMADRID, Apr 5 2022 (IPS) While the world’s top scientists and experts continue their arduous work to finally submit to politicians at the 27th session of the Conference of the Parties (COP 27) in Sharm El-Sheikh, Egypt (7-18 November 2022), a new alert now emerges: the climate crisis has already become the single biggest health threat to humankind. But this new alert should be no surprise: it rather constitutes the logic, expected cons...
Source: IPS Inter Press Service - Health - April 5, 2022 Category: International Medicine & Public Health Authors: Baher Kamal Tags: Development & Aid Environment Global Headlines Health TerraViva United Nations World Health Day Source Type: news

UCLA-led team gets $8.4 million NIH grant to probe mysteries of Valley Fever
Why do some people infected with Valley Fever develop a potentially fatal form of the disease that ravages their body while most experience only mild symptoms or none at all?A team led by UCLA ’s Dr. Manish Butte has been awarded an $8.4 million grant from the National Institute of Allergy and Infectious Diseases to study this and other questions related to genetic risk factors and immune responses to the disease, which occurs when people breathe in microscopic spores of the fungusCoccidioides that are present in soil.First identified in Argentina in the late 1800s, Valley Fever today is seen in a geographic swath that s...
Source: UCLA Newsroom: Health Sciences - February 15, 2022 Category: Universities & Medical Training Source Type: news

NIH supports Valley Fever research with new award
Teams will collaborate to investigate potential diagnostics, therapeutics, and vaccines for this fungal disease. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - February 2, 2022 Category: American Health Source Type: news

Kenya: Top Scientist Shares the Joys and Challenges of Creating Life-Saving Vaccines
[The Conversation Africa] Professor George Warimwe should be a household name in Kenya. He's a leading scientist who has created a life-saving vaccine against Rift Valley Fever. He is also leading policy-changing work on Yellow Fever vaccines. Warimwe has now been awarded the Royal Society Africa Prize for his work on vaccine development and capacity building in Africa. Moina Spooner, from The Conversation Africa, spoke to Warimwe about his life as a vaccinologist. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 1, 2021 Category: African Health Source Type: news

New Analyses Suggest Favorable Results for STELARA ® (ustekinumab) When Used as a First-Line Therapy for Bio-Naïve Patients with Moderately to Severely Active Crohn’s Disease and Ulcerative Colitis
SPRING HOUSE, PENNSYLVANIA, October 25, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from two new analyses of STELARA® (ustekinumab) for the treatment of adults with moderately to severely active Crohn’s disease (CD) and ulcerative colitis (UC).1,2 In a modelled analysisa focused on treatment sequencing using data from randomized controlled trials, network meta-analysis and literature, results showed patient time spent in clinical remission or response was highest when STELARA was used as a first-line advanced therapy for bio-naïve patients with moderately to severely acti...
Source: Johnson and Johnson - October 25, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Epidemiology, Features, and Outcomes of Coccidioidomycosis Epidemiology, Features, and Outcomes of Coccidioidomycosis
A recent study of coccidioidomycosis provides insight into the epidemiology, clinical characteristics, and outcomes of this infection.Emerging Infectious Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 30, 2021 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news